Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Medtronic
Express Scripts
QuintilesIMS
Chubb
Boehringer Ingelheim
McKinsey
US Army

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205258

« Back to Dashboard

NDA 205258 describes NEVIRAPINE, which is a drug marketed by Aurobindo, Cipla Ltd, Alvogen Malta, Apotex Inc, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Sandoz Inc, Tech Organized, Cipla, Hetero Labs Ltd Iii, Micro Labs Ltd, Mylan Labs, Prinston Inc, and Strides Pharma, and is included in twenty-two NDAs. It is available from sixteen suppliers. Additional details are available on the NEVIRAPINE profile page.

The generic ingredient in NEVIRAPINE is nevirapine. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the nevirapine profile page.
Summary for 205258
Tradename:NEVIRAPINE
Applicant:Apotex Inc
Ingredient:nevirapine
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 205258
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 205258 ANDA Apotex Corp 60505-4058 N 60505-4058-0
NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 205258 ANDA Apotex Corp 60505-4058 N 60505-4058-3

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength400MG
Approval Date:Apr 3, 2014TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Department of Justice
Express Scripts
Julphar
Farmers Insurance
Queensland Health
Dow
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.